{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:52:37Z","timestamp":1760403157667,"version":"build-2065373602"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10067-025-07674-8","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:47:56Z","timestamp":1757324876000},"page":"3945-3958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge mapping of plasmacytoid dendritic cells in systemic lupus erythematosus: a bibliometric analysis (2004\u20132023)"],"prefix":"10.1007","volume":"44","author":[{"given":"Yuan","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-0272","authenticated-orcid":false,"given":"Zhifang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"7674_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","volume":"41","author":"S Caielli","year":"2023","unstructured":"Caielli S, Wan Z, Pascual V (2023) Systemic lupus erythematosus pathogenesis: interferon and beyond. Annu Rev Immunol 41:533\u2013560","journal-title":"Annu Rev Immunol"},{"key":"7674_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","volume":"74","author":"S Lazar","year":"2023","unstructured":"Lazar S, Kahlenberg JM (2023) Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med 74:339\u2013352","journal-title":"Annu Rev Med"},{"key":"7674_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102861","volume":"132","author":"H Lou","year":"2022","unstructured":"Lou H, Ling GS, Cao X (2022) Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target. J Autoimmun 132:102861","journal-title":"J Autoimmun"},{"issue":"1","key":"7674_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/joim.13557","volume":"293","author":"J Frosteg\u00e5rd","year":"2023","unstructured":"Frosteg\u00e5rd J (2023) Systemic lupus erythematosus and cardiovascular disease. J Intern Med 293(1):48\u201362","journal-title":"J Intern Med"},{"issue":"3","key":"7674_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","volume":"15","author":"N Schwartz","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C (2019) Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol 15(3):137\u2013152","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7674_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH et al (2020) Lupus nephritis. Nat Rev Dis Primers 6(1):7","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"7674_CR7","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen A, M\u00fcller F, Mougiakakos D et al (2022) Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med 28(10):2124\u20132132","journal-title":"Nat Med"},{"issue":"6","key":"7674_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano S, Milone A, Nicoletti GF et al (2023) Precision medicine in systemic lupus erythematosus. Nat Rev Rheumatol 19(6):331\u2013342","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"7674_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","volume":"50","author":"B Reizis","year":"2019","unstructured":"Reizis B (2019) Plasmacytoid dendritic cells: development, regulation, and function. Immunity 50(1):37\u201350","journal-title":"Immunity"},{"issue":"9","key":"7674_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid D, Hong S, Marches R et al (2020) Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol 21(9):1094\u20131106","journal-title":"Nat Immunol"},{"issue":"1","key":"7674_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek SK, Cueto FJ, Mujal AM et al (2020) Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol 20(1):7\u201324","journal-title":"Nat Rev Immunol"},{"key":"7674_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102856","volume":"132","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang X, Cao X (2022) Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications. J Autoimmun 132:102856","journal-title":"J Autoimmun"},{"issue":"1","key":"7674_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.autrev.2017.11.009","volume":"17","author":"F Chasset","year":"2018","unstructured":"Chasset F, Arnaud L (2018) Targeting interferons and their pathways in systemic lupus erythematosus. Autoimmun Rev 17(1):44\u201352","journal-title":"Autoimmun Rev"},{"issue":"11","key":"7674_CR14","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","volume":"75","author":"M Khamashta","year":"2016","unstructured":"Khamashta M, Merrill JT, Werth VP et al (2016) Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis 75(11):1909\u20131916","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7674_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y et al (2020) Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med 382(3):211\u2013221","journal-title":"N Engl J Med"},{"issue":"2","key":"7674_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523\u2013538","journal-title":"Scientometrics"},{"key":"7674_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1194738","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang S, Zhang L, Jin Z et al (2023) Visualizing temporal dynamics and research trends of macrophage-related diabetes studies between 2000 and 2022: a bibliometric analysis. Front Immunol 14:1194738","journal-title":"Front Immunol"},{"key":"7674_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu15153442","author":"H He","year":"2023","unstructured":"He H, Liu C, Chen M et al (2023) Effect of dietary patterns on inflammatory bowel disease: a machine learning bibliometric and visualization analysis. Nutrients. https:\/\/doi.org\/10.3390\/nu15153442","journal-title":"Nutrients"},{"key":"7674_CR19","first-page":"724","volume":"2005","author":"MB Synnestvedt","year":"2005","unstructured":"Synnestvedt MB, Chen C, Holmes JH (2005) CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc 2005:724\u2013728","journal-title":"AMIA Annu Symp Proc"},{"issue":"4","key":"7674_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C (2017) Bibliometrix\u202f: an R-tool for comprehensive science mapping analysis. J Informetr 11(4):959\u2013975","journal-title":"J Informetr"},{"issue":"1","key":"7674_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40537-023-00744-1","volume":"10","author":"I Mitrovi\u0107","year":"2023","unstructured":"Mitrovi\u0107 I, Mi\u0161i\u0107 M, Proti\u0107 J (2023) Exploring high scientific productivity in international co-authorship of a small developing country based on collaboration patterns. J Big Data 10(1):64","journal-title":"J Big Data"},{"key":"7674_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/17534666231155748","volume":"17","author":"X Lv","year":"2023","unstructured":"Lv X, Gao Z, Tang W et al (2023) Trends of therapy in the treatment of asthma. Ther Adv Respir Dis 17:17534666231155748","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"7674_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/1744666X.2023.2268284","volume":"20","author":"N Gensous","year":"2024","unstructured":"Gensous N, Lazaro E, Blanco P et al (2024) Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus. Expert Rev Clin Immunol 20(1):21\u201330","journal-title":"Expert Rev Clin Immunol"},{"key":"7674_CR24","doi-asserted-by":"crossref","unstructured":"Bao A, Petri MA, Fava A et al (2024) Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE. Lupus Sci Med  10(2):e001007","DOI":"10.1136\/lupus-2023-001007"},{"key":"7674_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/kead104.205","volume":"62","author":"LM Carter","year":"2023","unstructured":"Carter LM, Wigston Z, Laws P et al (2023) An emerging role of interferon targeted therapy in mucocutaneous SLE: a prospective real-world evaluation of anifrolumab for refractory cutaneous lupus. Rheumatology 62:1","journal-title":"Rheumatology"},{"key":"7674_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/annrheumdis-2023-eular.2704","volume":"82","author":"R Furie","year":"2023","unstructured":"Furie R, Werth V, Milliman E et al (2023) Effect of litifilimab on type I interferon (IFN) biomarkers in patients with systemic lupus erythematosus (SLE) or cutaneous lupus erythematosus (CLE): result of the LILAC phase 2 study. Ann Rheum Dis 82:1453\u20131454","journal-title":"Ann Rheum Dis"},{"key":"7674_CR27","first-page":"1068","volume":"82","author":"A Bj\u00f6rk","year":"2023","unstructured":"Bj\u00f6rk A, Wahadat MJ, Braams M et al (2023) Amlexanox inhibits production of type i interferon and suppresses b cell differentiation and immunoglobulin production in vitro: a potential novel therapeutic option for SLE. Annals of the rheumatic diseases 82:1068","journal-title":"Annals of the rheumatic diseases"},{"key":"7674_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2016.11.006","volume":"188","author":"PPC Boor","year":"2017","unstructured":"Boor PPC, de Ruiter PE, Asmawidjaja PS et al (2017) Jak-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. Transl Res 188:67\u201379","journal-title":"Transl Res"},{"issue":"1","key":"7674_CR29","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","volume":"12","author":"SA Hasni","year":"2021","unstructured":"Hasni SA, Gupta S, Davis M et al (2021) Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus. Nat Commun 12(1):3391","journal-title":"Nat Commun"},{"issue":"10","key":"7674_CR30","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.20132620","volume":"211","author":"SL Rowland","year":"2014","unstructured":"Rowland SL, Riggs JM, Gilfillan S et al (2014) Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J Exp Med 211(10):1977\u20131991","journal-title":"J Exp Med"},{"issue":"10","key":"7674_CR31","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1084\/jem.20132522","volume":"211","author":"V Sisirak","year":"2014","unstructured":"Sisirak V, Ganguly D, Lewis KL et al (2014) Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med 211(10):1969\u20131976","journal-title":"J Exp Med"},{"issue":"73","key":"7674_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001180","volume":"3","author":"R Lande","year":"2011","unstructured":"Lande R, Ganguly D, Facchinetti V et al (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3(73):73ra19","journal-title":"Sci Transl Med"},{"issue":"8","key":"7674_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki M, Colonna M (2015) The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 15(8):471\u2013485","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"7674_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2358","volume":"8","author":"M Gilliet","year":"2008","unstructured":"Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8(8):594\u2013606","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"7674_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.immuni.2022.01.016","volume":"55","author":"J Feng","year":"2022","unstructured":"Feng J, Pucella JN, Jang G et al (2022) Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells. Immunity 55(3):405\u201322.e11","journal-title":"Immunity"},{"issue":"2","key":"7674_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","volume":"53","author":"U Cytlak","year":"2020","unstructured":"Cytlak U, Resteu A, Pagan S et al (2020) Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans. Immunity 53(2):353\u201370.e8","journal-title":"Immunity"},{"issue":"1","key":"7674_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","volume":"135","author":"B Cisse","year":"2008","unstructured":"Cisse B, Caton ML, Lehner M et al (2008) Transcription factor E2\u20132 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135(1):37\u201348","journal-title":"Cell"},{"key":"7674_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071525","author":"FJ Cueto","year":"2021","unstructured":"Cueto FJ, Sancho D (2021) The Flt3L\/Flt3 axis in dendritic cell biology and cancer immunotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13071525","journal-title":"Cancers (Basel)"},{"key":"7674_CR39","doi-asserted-by":"crossref","unstructured":"Grzes KM, Sanin DE, Kabat AM et al (2021) Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters. Immunity 54(11):2514\u201330.e7","DOI":"10.1016\/j.immuni.2021.10.009"},{"issue":"1","key":"7674_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.immuni.2018.11.010","volume":"50","author":"M Chopin","year":"2019","unstructured":"Chopin M, Lun AT, Zhan Y et al (2019) Transcription factor PU.1 promotes conventional dendritic cell identity and function via induction of transcriptional regulator DC-SCRIPT. Immunity 50(1):77-90.e5","journal-title":"Immunity"},{"key":"7674_CR41","doi-asserted-by":"publisher","unstructured":"Northcott M, Jones S, Koelmeyer R et al (2022) Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis. Lupus Sci  Med 9(1). https:\/\/doi.org\/10.1136\/lupus-2021-000625","DOI":"10.1136\/lupus-2021-000625"},{"issue":"6","key":"7674_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/annrheumdis-2021-221835","volume":"81","author":"F Chasset","year":"2022","unstructured":"Chasset F, Mathian A, Dorgham K et al (2022) Serum interferon-\u03b1 levels and IFN type i-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity. Ann Rheum Dis 81(6):901\u2013903","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7674_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000270","volume":"6","author":"L R\u00f6nnblom","year":"2019","unstructured":"R\u00f6nnblom L, Leonard D (2019) Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med 6(1):e000270","journal-title":"Lupus Sci Med"},{"issue":"8","key":"7674_CR44","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1084\/jem.20050914","volume":"202","author":"FJ Barrat","year":"2005","unstructured":"Barrat FJ, Meeker T, Gregorio J et al (2005) Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202(8):1131\u20131139","journal-title":"J Exp Med"},{"issue":"8","key":"7674_CR45","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1182\/blood-2005-07-2650","volume":"107","author":"E Savarese","year":"2006","unstructured":"Savarese E, Chae OW, Trowitzsch S et al (2006) U1 small nuclear ribonucleoprotein immune complexes induce type i interferon in plasmacytoid dendritic cells through TLR7. Blood 107(8):3229\u20133234","journal-title":"Blood"},{"issue":"7300","key":"7674_CR46","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature09102","volume":"465","author":"C Guiducci","year":"2010","unstructured":"Guiducci C, Gong M, Xu Z et al (2010) TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465(7300):937\u2013941","journal-title":"Nature"},{"issue":"12","key":"7674_CR47","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1002\/eji.200737815","volume":"37","author":"FJ Barrat","year":"2007","unstructured":"Barrat FJ, Meeker T, Chan JH et al (2007) Treatment of lupus\u2010prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37(12):3582\u20133586","journal-title":"Eur J Immunol"},{"issue":"6","key":"7674_CR48","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.4049\/jimmunol.1801521","volume":"202","author":"O Rahaman","year":"2019","unstructured":"Rahaman O, Bhattacharya R, Liu CSC et al (2019) Cutting edge: dysregulated endocannabinoid-rheostat for plasmacytoid dendritic cell activation in a systemic lupus endophenotype. J Immunol 202(6):1674\u20131679","journal-title":"J Immunol"},{"issue":"2","key":"7674_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1084\/jem.20050338","volume":"202","author":"SR Christensen","year":"2005","unstructured":"Christensen SR, Kashgarian M, Alexopoulou L et al (2005) Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202(2):321\u2013331","journal-title":"J Exp Med"},{"issue":"3","key":"7674_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR, Shupe J, Nickerson K et al (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3):417\u2013428","journal-title":"Immunity"},{"issue":"4","key":"7674_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaut.2009.11.001","volume":"34","author":"ML Santiago-Raber","year":"2010","unstructured":"Santiago-Raber ML, Dunand-Sauthier I, Wu T et al (2010) Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun 34(4):339\u2013348","journal-title":"J Autoimmun"},{"issue":"4","key":"7674_CR52","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.4049\/jimmunol.1501943","volume":"197","author":"L Bossaller","year":"2016","unstructured":"Bossaller L, Christ A, Pelka K et al (2016) TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus. J Immunol 197(4):1044\u20131053","journal-title":"J Immunol"},{"issue":"6","key":"7674_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L, Palucka AK, Arce E et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6):711\u2013723","journal-title":"J Exp Med"},{"issue":"8","key":"7674_CR54","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/art.24634","volume":"60","author":"A Midgley","year":"2009","unstructured":"Midgley A, McLaren Z, Moots RJ et al (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60(8):2390\u20132401","journal-title":"Arthritis Rheum"},{"issue":"73","key":"7674_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo GS, Caielli S, Vega B et al (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3(73):73ra20","journal-title":"Sci Transl Med"},{"issue":"10","key":"7674_CR56","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41577-021-00614-y","volume":"21","author":"V Brinkmann","year":"2021","unstructured":"Brinkmann V, Zychlinsky A (2021) Entering the neutrophil trap. Nat Rev Immunol 21(10):615","journal-title":"Nat Rev Immunol"},{"issue":"5546","key":"7674_CR57","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","volume":"294","author":"P Blanco","year":"2001","unstructured":"Blanco P, Palucka AK, Gill M et al (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294(5546):1540\u20131543","journal-title":"Science"},{"issue":"4","key":"7674_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","volume":"14","author":"D Braun","year":"2002","unstructured":"Braun D, Caramalho I, Demengeot J (2002) IFN-alpha\/beta enhances BCR-dependent B cell responses. Int Immunol 14(4):411\u2013419","journal-title":"Int Immunol"},{"issue":"1","key":"7674_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2567.2010.03280.x","volume":"131","author":"A Golding","year":"2010","unstructured":"Golding A, Rosen A, Petri M et al (2010) Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses. Immunology 131(1):107\u2013117","journal-title":"Immunology"},{"issue":"5","key":"7674_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/icb.2012.10","volume":"90","author":"K Kiefer","year":"2012","unstructured":"Kiefer K, Oropallo MA, Cancro MP et al (2012) Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol 90(5):498\u2013504","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"7674_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","volume":"44","author":"M Menon","year":"2016","unstructured":"Menon M, Blair PA, Isenberg DA et al (2016) A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44(3):683\u2013697","journal-title":"Immunity"},{"key":"7674_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.06.002","volume":"103","author":"SJ Wolf","year":"2019","unstructured":"Wolf SJ, Estadt SN, Theros J et al (2019) Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells. J Autoimmun 103:102291","journal-title":"J Autoimmun"},{"issue":"10","key":"7674_CR63","first-page":"575","volume":"18","author":"A Psarras","year":"2022","unstructured":"Psarras A, Wittmann M, Vital EM (2022) Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat Rev Rheumatol 18(10):575\u2013590","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"7674_CR64","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/art.39962","volume":"69","author":"R Furie","year":"2017","unstructured":"Furie R, Khamashta M, Merrill JT et al (2017) Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheumatol 69(2):376\u2013386","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"7674_CR65","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI124466","volume":"129","author":"R Furie","year":"2019","unstructured":"Furie R, Werth VP, Merola JF et al (2019) Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J Clin Invest 129(3):1359\u20131371","journal-title":"J Clin Invest"},{"key":"7674_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01510","volume":"9","author":"S Kubo","year":"2018","unstructured":"Kubo S, Nakayamada S, Sakata K et al (2018) Janus kinase inhibitor baricitinib modulates human innate and adaptive immune system. Front Immunol 9:1510","journal-title":"Front Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07674-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07674-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07674-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:25:29Z","timestamp":1760365529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07674-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7674"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07674-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study exclusively involved data sourced from the Web of Science database, without the inclusion of human participants or laboratory animals, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s note"}}]}}